ArticleBiomolecules & therapeutics2022

Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects.

Hyo Jeong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.